SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PHARMERICA (DOSE) - Undervalued Growth Company
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Dancy who wrote (3)10/31/1998 11:14:00 AM
From: Rob Anderson  Read Replies (1) of 24
 
Joe its very nice the way you put this thread together thanks for the effort. I'm long on DOSE and consider it an intriguing play. I find it interesting that DOSE missed earnings estimate by .02 on 88 mil. shares that equates to 1.76 million dollars mere peanuts compared to the revenue produced. It would not be difficult to turn this ship around!
Someone pointed out the PE that Omnicare carries 30 I believe, it would be awsome if DOSE could achieve this number 6-9 months?

Thanks again Rob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News